Advanced Plant Pharmaceuticals, Inc. Completes $500,000 Private Placement; Working Capital Helps Expand Marketing Initiatives.

Business Editors/Health/Medical Writers

NEW YORK--(BUSINESS WIRE)--Oct. 16, 2003

Advanced Plant Pharmaceuticals, Inc. (APPI), a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop all-natural Whole Plant Pharmaceuticals and Nutritionals, is pleased to announce that the company has already received the outstanding balance of $200,000 of a previously announced financing commitment of $500,000 from a private investor. The private placement was at a fixed price per share.

This financing provides the working capital to pursue the company's business plan on a broad front, protecting the intellectual property of the company's products by building a portfolio, establishing marketing partners with domestic and international experts and conducting clinical studies on Lo-Chol with the goal of obtaining a disease claim approval for the lowering of cholesterol to enhance APPI's marketing.

Another example of APPI's increased activity in building sales momentum for its products is the recently announced agreement with Ed McMahon as spokesperson for a series of infomercials for Lo-Chol to be aired in the near future. The signing of Mr. McMahon supplements the current Lo-Chol telemarketing campaign. Mr. McMahon, veteran of the popular "The Tonight Show" with Johnny Carson, will bring a higher profile to APPI's flagship product, Lo-Chol, as the infomercials that will be produced and aired by APPI's marketing partner, NutraLife Pharmaceuticals, Corp. begin their media schedule.

Lo-Chol(TM) is a cholesterol-lowering supplement that has shown through human clinical studies to improve HDL/LDL ratio's and reduce overall cholesterol. Lo-Chol(TM) is a unique, proprietary supplement that is produced utilizing APPI's patent pending "Whole Plant" process which develops whole plant pharmaceuticals and nutritionals (http://www.uspto.gov). In 2002, sales of cholesterol drugs exceeded $17 billion, according to Decision Resources, a Waltham, Mass.-based pharmaceutical industry research firm. According to the American Heart Association (www.americanheart.org), it is estimated that 102.3 million American adults have total blood cholesterol values of 200 mg/dl and higher, and about 41.3 million American adults have levels of 240 or above. In adults, total cholesterol levels of 240 mg/dl or higher are considered high, and levels from 200 to 239 mg/dl are considered borderline-high.

About Advanced Plant Pharmaceuticals, Inc.

Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of plant-based dietary and health supplements. The Company has a patent pending process that utilizes whole plants to manufacture all natural dietary and health supplements. APPI uses this process to manufacture products, which the company distributes worldwide through various marketing and distribution contracts. Current products include Sinusol (homeopathic allergy and nasal spray), Garlic, ABAVCA(TM) (immune system booster) and Lo-Chol(TM) (cholesterol-lowering supplement). Corporate website: www.appi.cc

FORWARD LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.